中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/11/14 | 6,940 | 6,990 | 6,840 | 6,880 | +10 | +0.1% | 661,100 |
| 2018/11/13 | 6,840 | 6,880 | 6,730 | 6,870 | -20 | -0.3% | 777,100 |
| 2018/11/12 | 6,850 | 6,950 | 6,800 | 6,890 | +30 | +0.4% | 434,000 |
| 2018/11/09 | 7,010 | 7,050 | 6,830 | 6,860 | -110 | -1.6% | 925,300 |
| 2018/11/08 | 6,920 | 7,020 | 6,900 | 6,970 | +200 | +3% | 679,000 |
| 2018/11/07 | 6,780 | 6,850 | 6,730 | 6,770 | -30 | -0.4% | 728,700 |
| 2018/11/06 | 6,760 | 6,850 | 6,720 | 6,800 | +120 | +1.8% | 634,100 |
| 2018/11/05 | 6,620 | 6,700 | 6,560 | 6,680 | +70 | +1.1% | 811,100 |
| 2018/11/02 | 6,430 | 6,660 | 6,410 | 6,610 | +250 | +3.9% | 1,368,900 |
| 2018/11/01 | 6,570 | 6,600 | 6,340 | 6,360 | -270 | -4.1% | 1,176,300 |
| 2018/10/31 | 6,500 | 6,640 | 6,470 | 6,630 | +70 | +1.1% | 810,200 |
| 2018/10/30 | 6,610 | 6,670 | 6,540 | 6,560 | -20 | -0.3% | 905,900 |
| 2018/10/29 | 6,660 | 6,700 | 6,580 | 6,580 | +10 | +0.2% | 554,100 |
| 2018/10/26 | 6,620 | 6,700 | 6,500 | 6,570 | +50 | +0.8% | 1,079,200 |
| 2018/10/25 | 6,540 | 6,620 | 6,410 | 6,520 | -150 | -2.2% | 1,274,600 |
| 2018/10/24 | 6,760 | 6,780 | 6,640 | 6,670 | -10 | -0.1% | 807,600 |
| 2018/10/23 | 6,740 | 6,800 | 6,670 | 6,680 | -150 | -2.2% | 912,200 |
| 2018/10/22 | 6,830 | 6,880 | 6,750 | 6,830 | +30 | +0.4% | 472,600 |
| 2018/10/19 | 6,640 | 6,820 | 6,640 | 6,800 | -10 | -0.1% | 643,700 |
| 2018/10/18 | 6,810 | 6,840 | 6,790 | 6,810 | +20 | +0.3% | 591,900 |
| 2018/10/17 | 6,810 | 6,860 | 6,760 | 6,790 | -10 | -0.1% | 930,700 |
| 2018/10/16 | 6,720 | 6,830 | 6,700 | 6,800 | +140 | +2.1% | 1,331,900 |
| 2018/10/15 | 6,670 | 6,760 | 6,620 | 6,660 | -80 | -1.2% | 1,003,500 |
| 2018/10/12 | 6,700 | 6,770 | 6,610 | 6,740 | -60 | -0.9% | 1,624,700 |
| 2018/10/11 | 6,780 | 6,860 | 6,700 | 6,800 | -130 | -1.9% | 1,653,100 |
| 2018/10/10 | 6,910 | 6,970 | 6,820 | 6,930 | ±0 | ±0% | 1,087,400 |
| 2018/10/09 | 7,080 | 7,170 | 6,910 | 6,930 | -110 | -1.6% | 1,167,400 |
| 2018/10/05 | 7,050 | 7,160 | 6,980 | 7,040 | -60 | -0.8% | 1,218,500 |
| 2018/10/04 | 7,490 | 7,500 | 7,060 | 7,100 | -400 | -5.3% | 1,870,100 |
| 2018/10/03 | 7,510 | 7,540 | 7,440 | 7,500 | ±0 | ±0% | 1,046,700 |
| 2018/10/02 | 7,530 | 7,550 | 7,420 | 7,500 | +110 | +1.5% | 1,300,800 |
| 2018/10/01 | 7,400 | 7,440 | 7,330 | 7,390 | +90 | +1.2% | 802,700 |
| 2018/09/28 | 7,220 | 7,370 | 7,180 | 7,300 | +150 | +2.1% | 1,132,700 |
| 2018/09/27 | 7,110 | 7,310 | 7,060 | 7,150 | ±0 | ±0% | 1,051,700 |
| 2018/09/26 | 7,140 | 7,150 | 7,070 | 7,150 | +10 | +0.1% | 929,300 |
| 2018/09/25 | 7,100 | 7,160 | 7,060 | 7,140 | +120 | +1.7% | 1,045,600 |
| 2018/09/21 | 7,100 | 7,110 | 6,970 | 7,020 | -10 | -0.1% | 1,205,200 |
| 2018/09/20 | 6,960 | 7,050 | 6,950 | 7,030 | +50 | +0.7% | 1,038,200 |
| 2018/09/19 | 6,840 | 7,060 | 6,830 | 6,980 | +200 | +2.9% | 1,002,200 |
| 2018/09/18 | 6,670 | 6,820 | 6,660 | 6,780 | +110 | +1.6% | 1,182,700 |
| 2018/09/14 | 6,680 | 6,700 | 6,610 | 6,670 | -10 | -0.1% | 1,670,400 |
| 2018/09/13 | 6,600 | 6,700 | 6,590 | 6,680 | +90 | +1.4% | 918,000 |
| 2018/09/12 | 6,610 | 6,650 | 6,560 | 6,590 | -50 | -0.8% | 775,300 |
| 2018/09/11 | 6,600 | 6,740 | 6,600 | 6,640 | +60 | +0.9% | 887,300 |
| 2018/09/10 | 6,540 | 6,600 | 6,520 | 6,580 | +50 | +0.8% | 653,200 |
| 2018/09/07 | 6,530 | 6,600 | 6,460 | 6,530 | +10 | +0.2% | 843,600 |
| 2018/09/06 | 6,450 | 6,520 | 6,410 | 6,520 | +40 | +0.6% | 778,000 |
| 2018/09/05 | 6,470 | 6,500 | 6,440 | 6,480 | -10 | -0.2% | 680,800 |
| 2018/09/04 | 6,480 | 6,490 | 6,410 | 6,490 | -10 | -0.2% | 674,300 |
| 2018/09/03 | 6,440 | 6,520 | 6,430 | 6,500 | +60 | +0.9% | 545,000 |
1651～
1700
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 627,000円 | +1.7% | +5.0% | 3.99% | 25.17倍 | 5.20倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 武 田 | 458,900円 | -1.1% | +75.3% | 4.36% | 31.79倍 | 1.05倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 第一三共 | 370,000円 | +6.0% | +4.0% | 2.11% | 22.83倍 | 4.22倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 大塚ＨＤ | 806,600円 | +2.2% | +28.0% | 1.74% | 12.91倍 | 1.56倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 169,200円 | +0.9% | +380.2% | 4.61% | 23.31倍 | 2.00倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
